Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis

European Respiratory Journal

Volumn 48, Issue 6, 2016, Pages 1658-1667

  Stamm, Adriana ^a   Saxer, Stéphanie ^a   Lichtblau, Mona ^a   Hasler, Elisabeth D ^a   Jordan, Suzana ^a   Huber, Lars C ^a   Bloch, Konrad E ^a   Distler, Oliver ^a   Ulrich, Silvia ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ARTICLE; CHILD; CONTROLLED STUDY; EXERCISE; EXERCISE INDUCED PULMONARY HYPERTENSION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART CATHETERIZATION; HEART OUTPUT; HUMAN; LUNG ARTERY PRESSURE; LUNG FUNCTION; LUNG HEMODYNAMICS; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; SURVIVAL; SYSTEMIC SCLEROSIS; TOTAL LUNG CAPACITY; ADULT; AGED; COMPLICATION; EXERCISE TEST; EXERCISE TOLERANCE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PULMONARY ARTERY; VASCULAR RESISTANCE;

ADULT; AGED; CARDIAC CATHETERIZATION; CARDIAC OUTPUT; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; SCLERODERMA, SYSTEMIC; VASCULAR RESISTANCE;

EID: 85006113587     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00990-2016     Document Type: Article

References (40)

1. Condliffe R, Kiely DG, Peacock AJ, et al. Connective tissue disease-Associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009; 179: 151-157.
2. Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809-1815.
3. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792-3800.
4. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach. Ann Rheum Dis 2003; 62: 1088-1093.
5. Vonk MC, Broers B, Heijdra YF, et al. Systemic sclerosis and its pulmonary complications in The Netherlands: An epidemiological study. Ann Rheum Dis 2009; 68: 961-965.
6. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66: 940-944.
7. McLaughlin V, Humbert M, Coghlan G, et al. Pulmonary arterial hypertension: The most devastating vascular complication of systemic sclerosis. Rheumatology (Oxford) 2009; 48: Suppl.3, iii25-iii31.
8. Kawut SM, Taichman DB, Archer-Chicko CL, et al. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003; 123: 344-350.
9. Hachulla E, Carpentier P, Gressin V, et al. Risk factors for death and the 3-year survival of patients with systemic sclerosis: The French ItinérAIR-Sclérodermie study. Rheumatology (Oxford) 2009; 48: 304-308.
10. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl.25, D42-D50.
11. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: Suppl.1, S55-S66.
12. Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: A systematic review. Eur Respir J 2009; 34: 888-894.
13. Naeije R, Vonk Noordegraaf A, Kovacs G. Exercise-induced pulmonary hypertension: At last! Eur Respir J 2015; 46: 583-586.
14. Naeije R, Vanderpool R, Dhakal BP, et al. Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med 2013; 187: 576-583.
15. Kovacs G, Olschewski H. Borderline pulmonary pressures in scleroderma -A 'pre-pulmonary arterial hypertension' condition? Arthritis Res Ther 2015; 17: 123.
16. Hervé P, Lau EM, Sitbon O, et al. Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J 2015; 46: 728-737.
17. Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46: 903-975.
18. van den Hoogen F, Khanna D, Fransen J, et al. 2013 Classification criteria for systemic sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-2747.
19. Hasler ED, Müller-Mottet S, Furian M, et al. Pressure-flow during exercise catheterization predicts survival in pulmonary hypertension. Chest 2016; 150: 57-67.
20. Kovacs G, Avian A, Olschewski A, et al. Zero reference level for right heart catheterisation. Eur Respir J 2013; 42: 1586-1594.
21. Kovacs G, Avian A, Pienn M, et al. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 2014; 190: 252-257.
22. Reeves JT, Linehan JH, Stenmark KR. Distensibility of the normal human lung circulation during exercise. Am J Physiol Lung Cell Mol Physiol 2005; 288: L419-L425.
23. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: Suppl.1, S43-S54.
24. Saggar R, Khanna D, Furst DE, et al. Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum 2010; 62: 3741-3750.
25. Steen V, Chou M, Shanmugam V, et al. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008; 134: 146-151.
26. Tolle JJ, Waxman AB, Van Horn TL, et al. Exercise-induced pulmonary arterial hypertension. Circulation 2008; 118: 2183-2189.
27. Visovatti SH, Distler O, Coghlan JG, et al. Borderline pulmonary arterial pressure in systemic sclerosis patients: A post-hoc analysis of the DETECT study. Arthritis Res Ther 2014; 16: 493.
28. Hachulla E, de Groote P, Gressin V, et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum 2009; 60: 1831-1839.
29. Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48: 516-522.
30. Coghlan JG, Denton CP, Grünig E, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: The DETECT study. Ann Rheum Dis 2014; 73: 1340-1349.
31. Ninaber MK, Hamersma WB, Schouffoer AA, et al. Detection of pulmonary vasculopathy by novel analysis of oxygen uptake in patients with systemic sclerosis: Association with pulmonary arterial pressures. Clin Exp Rheumatol 2014; 32: 6 Suppl.86, S60-7.
32. Fisher MR, Mathai SC, Champion HC, et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006; 54: 3043-3050.
33. Rubenfire M, Huffman MD, Krishnan S, et al. Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era. Chest 2013; 144: 1282-1290.
34. Condliffe R, Howard LS. Connective tissue disease-Associated pulmonary arterial hypertension. F1000Prime Rep 2015; 7: 06.
35. Williams MH, Das C, Handler CE, et al. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart 2006; 92: 926-932.
36. Dorfmuller P, Humbert M, Perros F, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007; 38: 893-902.
37. Overbeek MJ, Vonk MC, Boonstra A, et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: A distinctive vasculopathy. Eur Respir J 2009; 34: 371-379.
38. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53: 1573-1619.
39. Le Pavec J, Humbert M, Mouthon L, et al. Systemic sclerosis-Associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2010; 181: 1285-1293.
40. Garin MC, Highland KB, Silver RM, et al. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol 2009; 36: 330-336.